We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
+10.31%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$3.83B
AUM Growth
+$365M
Cap. Flow
+$14.3M
Cap. Flow %
0.37%
Top 10 Hldgs %
46.82%
Holding
177
New
6
Increased
30
Reduced
82
Closed
1

Top Buys

Rank Stock Value
1
RUSHA icon
Rush Enterprises Class A
RUSHA
+$20M
2
LH icon
Labcorp
LH
+$18.1M
3
SCHW
Charles Schwab
SCHW
+$10.1M
4
ZWS icon
Zurn Elkay Water Solutions
ZWS
+$9.96M
5
WAT icon
Waters Corp
WAT
+$3.78M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$15.9M
2
MSFT icon
Microsoft
MSFT
+$14.2M
3
WMS icon
Advanced Drainage Systems
WMS
+$7.62M
4
MA icon
Mastercard
MA
+$3.36M
5
MDXG icon
MiMedx Group
MDXG
+$3.01M

Sector Composition

Rank Sector Weight
1 Financials 38.94%
2 Technology 13.69%
3 Healthcare 13.2%
4 Communication Services 7.56%
5 Industrials 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MMM icon
151
3M
MMM
$91.8B
$210K 0.01%
2,512
-7,275
-74% -$618K
BA icon
152
Boeing
BA
$169B
$210K 0.01%
994
– –
AMT icon
153
American Tower
AMT
$83.5B
$206K 0.01%
1,063
– –
SJT
154
San Juan Basin Royalty Trust
SJT
$119M
$177K ﹤0.01%
23,780
-15,400
-39% -$131K
VRCA icon
155
Verrica Pharmaceuticals
VRCA
$89M
$173K ﹤0.01%
3,000
– –
VTRS icon
156
Viatris
VTRS
$20.8B
$107K ﹤0.01%
10,699
– –
TMM
157
DELISTED
GRUPO TMM S.A.B. ADS REPTG FIVE ORD PART CERT SER A SH
TMM
$104K ﹤0.01%
238,233
– –
MDXG icon
158
MiMedx Group
MDXG
$630M
$97.1K ﹤0.01%
14,685
-590,993
-98% -$3.01M
RIG icon
159
Transocean
RIG
$5.48B
$70.1K ﹤0.01%
10,000
– –
AMRN
160
Amarin Corp
AMRN
$297M
$35.7K ﹤0.01%
1,500
– –
MIMO
161
DELISTED
Airspan Networks Holdings Inc
MIMO
$13.3K ﹤0.01%
80,000
– –
CAE icon
162
CAE Inc. Common Shares
CAE
$8.44B
– –
-9,900
Closed -$224K
VCMP
163
DELISTED
VCAMPUS CORP
VCMP
$0 ﹤0.01%
59,956
– –
3 4 5 6
7

Similar funds

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Beck Mack & Oliver's Q2 2023 Portfolio in Review

As of Q2 2023, Beck Mack & Oliver held 177 positions worth $3.83B, up 11% from $3.46B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 4%. Beck Mack & Oliver opened 6 new positions and exited 1, leaving the 177-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 39% a quarter earlier, followed by Technology and Healthcare.

  • Beck Mack & Oliver's largest Q2 2023 buy was Rush Enterprises Class A: 545,486 shares worth $22.1M.
  • Beck Mack & Oliver added most to Labcorp in Q2 2023, an estimated $18.1M increase.
  • Beck Mack & Oliver's biggest Q2 2023 reduction was Teva Pharmaceuticals, cutting an estimated $15.9M.
  • Beck Mack & Oliver fully exited CAE Inc. Common Shares in Q2 2023, selling an estimated $224K.
  • Beck Mack & Oliver's ten largest holdings make up 47% of its $3.83B portfolio in Q2 2023.
  • Beck Mack & Oliver opened 6 new positions and closed 1 in Q2 2023.
  • Beck Mack & Oliver's portfolio value rose 11% quarter-over-quarter to $3.83B.

Based on Beck Mack & Oliver's 13F filing for Q2 2023, filed 8 Aug 2023.